Methods of identifying compounds useful for treating autoimmune diseases
CA 2197233 C · Owner: Glimcher, Laurie H. · Inventors: Glimcher, Laurie H.; Zhou, Hong; Douhan, John, Iii
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are methods of identifying compounds which inhibit transcription activation by CIITA and thus inhibit MHC class II gene expression. Such compounds can affect the induction of an immune response. The methods employ independently, the activation and interactions domains of CIITA. The methods also employ the activation and interaction domains of isotype-specific CIITA proteins, allowing for the identification of compounds which are isotypespecific inhibitors of transcription and which are useful for selectively affecting the immune system.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 22, 1995 and granted February 20, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 22, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 22, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.